Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial is examining whether different types of messages emphasizing the health consequences of smoking, written at a 5th to 6th grade reading level, will have different effects on smokers with varying levels of health literacy.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 2 years
2 years
Factors that may influence how smokers understand smoking health risk informational messages.
Trial Safety
Safety Progress
Trial Design
4 Treatment Groups
Emotional Loss-Framed
1 of 4
Factual Loss-Framed
1 of 4
Emotional Gain-Framed
1 of 4
Factual Gain-Framed
1 of 4
Experimental Treatment
495 Total Participants · 4 Treatment Groups
Primary Treatment: Focus Group · No Placebo Group · N/A
Emotional Loss-FramedExperimental Group · 2 Interventions: Focus Group, Questionnaire · Intervention Types: Behavioral, Behavioral
Factual Loss-FramedExperimental Group · 2 Interventions: Focus Group, Questionnaire · Intervention Types: Behavioral, Behavioral
Emotional Gain-FramedExperimental Group · 2 Interventions: Focus Group, Questionnaire · Intervention Types: Behavioral, Behavioral
Factual Gain-FramedExperimental Group · 2 Interventions: Focus Group, Questionnaire · Intervention Types: Behavioral, Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Focus Group
2013
Completed Phase 1
~4140
Questionnaire
2014
Completed Phase 2
~20100
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
12,989 Previous Clinical Trials
41,298,563 Total Patients Enrolled
57 Trials studying Smoking
52,176 Patients Enrolled for Smoking
M.D. Anderson Cancer CenterLead Sponsor
2,779 Previous Clinical Trials
1,784,524 Total Patients Enrolled
13 Trials studying Smoking
3,937 Patients Enrolled for Smoking
Lorna H. McNeill, MPH,PHDPrincipal InvestigatorM.D. Anderson Cancer Center
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Who else is applying?
What state do they live in?
| Texas | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| University of Texas MD Anderson Cancer Center | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments